RepliCel Life Sciences 대차 대조표 상태
재무 상태 기준 확인 0/6
RepliCel Life Sciences has a total shareholder equity of CA$-5.0M and total debt of CA$1.2M, which brings its debt-to-equity ratio to -25%. Its total assets and total liabilities are CA$172.7K and CA$5.2M respectively.
주요 정보
-25.0%
부채 비율
CA$1.24m
부채
| 이자 보상 비율 | n/a |
| 현금 | CA$148.95k |
| 주식 | -CA$4.98m |
| 총 부채 | CA$5.15m |
| 총 자산 | CA$172.68k |
최근 재무 상태 업데이트
Recent updates
재무 상태 분석
단기부채: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: REPC.F has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: REPC.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
부채 범위: REPC.F's operating cash flow is negative, therefore debt is not well covered.
이자 보장: Insufficient data to determine if REPC.F's interest payments on its debt are well covered by EBIT.